Indiana University Simon Comprehensive Cancer Center — Indianapolis, Indiana

Indiana University Simon Comprehensive Cancer Center is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Indiana University Simon Comprehensive Cancer Center has participated in 10 clinical trials with 6 currently active.

Therapeutic areas: B-cell Lymphoma, Non Hodgkin Lymphoma, DLBCL.

Sponsors: Acepodia Biotech, Inc., TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics), Mayo Clinic.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University Simon Comprehensive Cancer Center?

Indiana University Simon Comprehensive Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University Simon Comprehensive Cancer Center conducted?

Indiana University Simon Comprehensive Cancer Center has 10 clinical trials on record, with 6 currently active. Their work covers B-cell Lymphoma, Non Hodgkin Lymphoma, DLBCL.

Is Indiana University Simon Comprehensive Cancer Center accredited by Crixeo Health?

Yes — Indiana University Simon Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Indiana University Simon Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.